Figure 6B shows the expression levels of ligands and receptors in the MDK-NCL signaling, in which midkine (MK, MDK) was mainly expressed in epithelial cells, metastatic tumor cells, and fibroblasts, and nucleolin (NCL) was expressed in all eight cell types. This evidence concerns the gene MDK and metastatic neoplasm.